The United States Department of Agriculture (USDA) recently announced it launched avian influenza vaccination clinic trials with animals in April 2023 to help mitigate the latest outbreak of highly pathogenic avian influenza (HPAI) in the United States.
The USDA's Agricultural Research Service (ARS) published Fact Sheet Release No. 0084.23, which confirmed researchers are currently testing several vaccine candidates.
Bird Flu Vaccines for Birds Launch Clinical Studies
Sleep Disturbance Common After COVID-19 Hospitalization
Associations seen for overall sleep quality, deterioration in sleep quality after admission, sleep regularity with higher dyspnea scores
Universal Masking in Health Care No Longer Seems Appropriate
Maintaining masking may offer marginal benefit in terms of reducing transmission, but impedes communication
COVID-19 Vaccines Do Not Increase Risk for New Retinal Vascular Occlusion
Rates within 21 days of vaccination extremely rare and similar to those with influenza and Tdap vaccines
Equatorial Guinea's Marburg Disease Fatalities Increase
The World Health Organization (WHO) today announced Equatorial Guinea (EG) continues facing an outbreak of Marburg Virus Disease (MVD) for the first time.
And as of April 15, 2023, the country's capacity to manage the outbreak must be strengthened.
In addition to the nine confirmed cases reported in the WHO's Disease Outbreak News of March 22, 2023, six more individuals tested positive for MVD, with one more affected EG province.
U.S. Continues Prepping Medical Countermeasures Against COVID-19
The U.S. HHS Secretary Xavier Becerra today announced that in the coming weeks, he would issue an amendment to the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19.
"While COVID-19 is not over, we are in a position to end the emergency phase of our response because of the Administration's whole-of-government approach to combatting the virus," wrote Secretary Becerra in a letter to U.S. governors on April 14, 2023.
U.S. Continues Preping Medical Countermeasures Against COVID-19
The U.S. HHS Secretary Xavier Becerra today announced that in the coming weeks, he would issue an amendment to the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19.
"While COVID-19 is not over, we are in a position to end the emergency phase of our response because of the Administration's whole-of-government approach to combatting the virus," wrote Secretary Becerra in a letter to U.S. governors on April 14, 2023.
Where is Cholera a Health Risk
Cholera pandemics have accelerated since mid-2021, according to a recent World Health Organization (WHO) statement that noted the pandemic’s “alarmingly high mortality rates.”
Cholera can be a life-threatening disease caused by bacteria called Vibrio cholerae. People get Cholera from unsafe food or water, says the WHO.
Sexually Transmitted Disease Epidemic Accelerates
The World Health Organization, the U.S. National Institutes of Health, and global partners have published a comprehensive roadmap for developing new vaccines against sexually transmitted infections (STIs).
Since its publication in 2014, vaccines for Mpox, human papillomavirus, and hepatitis have become readily available in the U.S.
India Reorders COVID-19 Vaccines
According to various media sources, India has responded to the recent increase in COVID-19 cases by ordering fresh supplies of vaccines.
For example, PTI reported on April 13, 2023, Serum Institute of India had restarted manufacturing of its CoviShield™ vaccine.